Estratto
Il cancro del colon retto (CCR) è una malattia ad elevata frequenza, potenzialmente letale, ma prevenibile. Uno degli strumenti di prevenzione più efficaci è lo screening, cioè l’offerta ad una popolazione a rischio per una malattia di un intervento atto a identificare e trattare con successo la malattia stessa.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Bibliografia
Ferlay J, Bray F, Pisani P et al GLOBOCAN (2002) Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base, No. 5, version 2.0. IARC Press, Lyon, 2004
Keighley MR, O’Morain C, Giacosa A et al (2004) Public awareness of risk factors and screening for colorectal cancer in Europe. 1 Eur J Cancer Prev 13:257–62
Sant M, Aareleid T, Berrino F and the EUROCARE Working Group (2003): EUROCARE-3 Survival of cancer patients diagnosed 1990–94. Results and commentary. Annals of Oncology 14:61–118.
Ries L, Kosary CL, Hankey BF et al (1998) SEER Cancer statistic review 1973–1995. National Cancer Institute, Bethesda
Eddy DM (1990). Screening for colorectal cancer. Ann Intern Med 13: 373–384
Ponz de Leon M, Passatelli R, Benfatti P et al (1993). Identification of hereditary non-polyps colorectal cancer in general population: the 6-year experience of a population-based registry. Cancer 71:3493–3501
Atkin WS, Morson BC, Cuzic J et al (1992) Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658–662
Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96:2992–3003
Cottet V, Pariente A, Nalet B et al (2007) Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 133:1086–1092
Fuchs CS, Giovannucci EL, Colditz GA et al (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331:1669–1674
Brentall TA, Haggitt RC, Rabinovitch PS et al (1996) Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110:331–8
Chambers WM, Warren BF, Jewell DP et al (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92:928–936
Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–104
Cho E, Smith-Warnr SA, Ritz J et al (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–13
Sturmer T, Glynnm RJ, Lee IM et al (2000) Lifetime cigarette smoking and colorectal cancer incidence in the physicians’ health study. J Natl Cancer Inst 92:1178–81
Zisman AL, Nickolov A, Brand RE et al (2006) Association between the age at diagnosis and location of colorectal cancer and use of alcohol and tobacco: implication for screening. Arch Intern Med 166:629–634
Slattery ML, Boucher KM, Caan BJ et al (1998) Eating patterns and risk of colon cancer. Am J Epidemiol 148:4–16
Michels KB, Giovannucci E, Joshipura KJ et al (2000) Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 92:1740–52
Chao A, Thun MJ, Connell CJ et al (2005) Meat consumption and risk of colorectal cancer. JAMA 293: 172–82
Bingham SA, Day NE, Luben R et al. (2003) Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361:1496–501.
Calle EE, Rodriguez C, Walzer K et al (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–38
Nilsen TI, Vatten LJ (2001) Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinemia hypothesis. Br J Cancer 84:417–22
Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–85
Yang X, Hennessy S, Lewis JD (2004) Insulin therapy and colorectal cancer among type 2 diabetes mellitus patient. Gastroenterology 127:1044–50
Rex DK and ACG Board of Trustees (2004) American College of Gastroenterology: action plan for colorectal cancer prevention. Am J Gastroenterol 99: 574–577
Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365–1371
Hardcastle JD, Chamberlain JO, Robinson MH et al (1996) Randomized controlled trial of faecal occult-blood screening for colorectal cancer. Lancet 348: 1472–77
Kronborg O, Fenger C, Olsen J et al (1996) Randomized study of screening for colorectal cancer with faecal occult-blood test. Lancet 348:1467–1471
Mandel JS, Church TR, Ederer F et al (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91:434–437
Kewenter J, Brevinge H, Engaras B et al (1994) Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68. 308 subjects. Scand J Gastroenterol 29:468–73
Moayyedi P, Achkr E (2006) Does faecal occult-blood testing reduce mortality? A reanalysis of sistematic data. Am J Gastroenterol 101:380–4
Church TR, Ederer F, Mandel JS (2002) All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 94:865–6
Lee KJ, Inoue M, Otani T et al (2007) Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan. Cancer Detection and Prevention 31:3–11
Crespi M, Lisi D (2002) Is colorectal cancer screening by fecal occult blood feasible? Annals of Oncology 13:47–50
Benson VS, Patnick J, Davies AK et al (2008) Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 122:1357–1367
Zorzi M, Barca A, Falcini F et al. (2007) Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 31: 49–60
Selby JV, Friedman GD, Quesenberry CP Jr et al (1992) A case control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657
Newcomb PA, Norfleet RG, Storer BE et al (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572–1575
Muller AD, Sonnenberg A (1995) Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155:1741–1748
Kavanagh AM, Giovannucci EL, Fuchs CS et al (1998) Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 9:455–462
Rex DK, Cummings OW, Helper DJ et al (1996) Five-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 111:1178–1181
Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977–1981
Citarda F, Tomaselli G, Capocaccia R et al (2001) Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48: 812–815
Lieberman DA, Weiss DG, Bond JH et al (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162–168
Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult blood testing and examination of the distal colon. N Engl J Med 345:555–560
Gatto NM, Frucht H, Sudarajan V et al (2003) Risk of perforation after colonoscopy and sigmoidoscopy: a population based study. J Ntl Cancer Inst 95:230–6
Schoenfeld P, Cash B, Flooe A et al (2005) Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352:2061–8
Imperiale TF, Wagner DR, Lin CY et al (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343:169–174
Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology 118:829–834
Levin TR, Zhao W, Conell C et al (2006) Complication of colonscopy in an integrated health care delivery sistem. Ann Intern Med 145:880–6
Crespi M, Lisi D (2007) Compliance to different screening modalities for colorectal cancer in Italy. Dig Liver Dis 39 S215
van Rijn JC, Reitsma JB, Stoker J et al (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101:343–50
Barclay RL, Vicari JJ, Doughty AS et al (2006) Colonscope with dawal times and adenoma detection during screening colonoscopy. N Engl J Med 355:2533–41
Winawer SJ, Zauber AG, O’Brien MJ et al (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328:901–906
Singh H, Turner D, Xue L et al. (2006) Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295:2366–73
Rex DK, Cummings OW, Helper DJ et al (1996) Five-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 111:1178–1181
Winawer SJ, Stewart ET, Zauber AG et al (2000) A comparison of colonoscopy and double contrast barium enema for the surveillance after polypectomy. National Polyp Study Group. N Engl J Med 342:1766–72
Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386:623–7
Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816–9
Imperiale TF, Ransohoff DF, Itzkowitz SH et al (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351:2704–14
Capurso L, Crespi M, Pacini F et al (2002) Linee guida su screening, diagnosi precoce e trattamento multidisciplinare del cancro del colon-retto. Agenzia per i Servizi Sanitari Regionali, Roma
Bertario L, Arrigoni A, Aste H et al (1997) Recommendation for clinical management of familial adenomatous polyposis. Tumori, 83:800–803
Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453–1456
Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A national cancer institute workshop on hereditary non-polyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762
Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology 118:829–834
Bertario L, Aste H, Arrigoni A et al (1996) Clinical aspects and management of Hereditary Non-Polyposis Colorectal Cancer (HNPCC). Tumori 82(2):117–121
Choi PM, Nugent FW, Schoetz DJJ et al (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105:418–424
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Fracasso, P., Crespi, M. (2008). Epidemiologia e razionale per lo screening. In: La colonscopia virtuale. Springer, Milano. https://doi.org/10.1007/978-88-470-1067-3_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-1067-3_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1066-6
Online ISBN: 978-88-470-1067-3
eBook Packages: MedicineMedicine (R0)